First antigen test pilot in low prevalence COVID-19 settings signals challenges for rollout
Research uncovers new potential target for ovarian cancer therapies
4 March 2021Germany’s Curevac says Novartis to help make COVID jabs
4 March 2021First antigen test pilot in low prevalence COVID-19 settings signals challenges for rollout
Melbourne researchers who conducted a pilot to study the performance and feasibility of utilizing antigen tests have identified several practical challenges in implementation for countries with a low COVID-19 prevalence.
